India is struggling with more number of dengue deaths each year. The Mexican Government has approved the world's first anti-dengue vaccine and this can be applied to people of age group from 9 to 45 years. There are four sub types of the virus. The first authorization is provided to Indian company as per sources.
The vaccine is called as Dengvaxia and it is developed by France-based Sanofi Pasteur and it is a result of an extensive clinical development program. Olivier Brandicourt said in a statement that, "We have finally achieved our goal of making dengue the next vaccine preventable disease.
We have market the authorization of Dengvaxia. This is indeed a milestone for our company, for all the health companies and whole health community. This is a boon to the people who live with the fear of receiving denture." Dengvaxia is the first vaccine to get license with respect to prevention of dengue.
The WHO has called on endemic countries to reduce dengue mortality by 50 per cent and morbidity by 25 per cent by 2020. Most scientists say that this is a major break through in field of health care.
